NGS MRD Negativity on Day 28 after Brexu Cel in Adults with R/R ALL Is Associated with Favorable Progression Free Survival
Yannis K. Valtis(Brigham and Women's Hospital), Shabaz Malik(St David's Medical Center), Rawan Faramand(Moffitt Cancer Center), Wendy Stock(University of Chicago), Joshua Sasine(Cedars-Sinai Medical Center), Catherine J. Lee(University of Utah), Simone E. Dekker(Oregon Health & Science University), Matthew L. Ulrickson, George Yaghmour(University of Tennessee Health Science Center), Navneet S. Majhail(Sarah Cannon), Marlise R. Luskin(Dana-Farber Cancer Institute), Matthew P. Connor(Hospital of the University of Pennsylvania), Vinod Pullarkat(City of Hope), Omer Jamy(University of Alabama at Birmingham Hospital), Jacob Boccucci(Augusta University Health), Jessica Leonard(Oregon Health & Science University), Evandro D. Bezerra(Cleveland Clinic), Tamer Othman(City Of Hope National Medical Center), Akil Merchant(Cedars-Sinai Medical Center), Ibrahim Aldoss(City of Hope), Michael R. Grunwald(Levine Cancer Institute), Gregory W. Roloff(University of Chicago), Noam E. Kopmar(University of Washington), Evan C. Chen(Dana-Farber Cancer Institute), Amelia Langston(CancerCare Manitoba), LaQuisa C. Hill(Baylor College of Medicine), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Kristen M. O'Dwyer(University of Rochester), Ibrahim N. Muhsen, Vamsi Kota(Augusta University), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Aaron C. Logan(University of California, San Francisco), Ryan D. Cassaday(University of Washington), Minoo Battiwalla(Sarah Cannon), Kaitlyn C. Dykes(University of California San Diego), David Nemirovsky(Memorial Sloan Kettering Cancer Center), Anjali S. Advani(Cleveland Clinic), Ran Reshef(Abramson Cancer Center), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Amy Zhang, Sumithira Vasu(The Ohio State University), Katherine C. Sutherland(Stanford University), Sean Devlin(Memorial Sloan Kettering Cancer Center), Jozal Moore(University of Rochester Medicine), Katharine Miller(Stanford University), Melhem Solh(Johns Hopkins Hospital)
Cited by 3
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737